Larazotide – 50MG (AT-1001) – 50MG per vial

Description

Clinical Test Expectation – Larazotide – 50MG – Human Subjects : Assists with Celiac Disease (CeD) and Inflammatory Bowel Disease (IBD)
Strength – 50MG per vial

Introduction.

Larazotide is a synthetic peptide derived from an enterotoxin found in bacteria. It acts by modulating intestinal permeability. In conditions like celiac disease and inflammatory bowel disease, there is increased intestinal permeability, often referred to as “leaky gut,” which allows unwanted substances to pass through the intestinal barrier. Larazotide aims to restore the normal functioning of tight junctions, which are specialized protein complexes that regulate the permeability of the intestinal lining. Larazotide is an altered, synthetic version of the cholera toxin. Research shows that it can modulate tight junctions, which allows it to alter intestinal permeability. In other words, larazotide helps to prevent the gut from leaking, a phenomenon that is thought to contribute to conditions like inflammatory bowel disease and celiac disease.

Dosing Details – Larazotide – 50MG
You inject 3ml water into the vial of Larazotide from the water vial. 1 full syringe is 1ml. you then wait for the vial powder content to dissolve and once dissolved and clear you draw out 3 (0.3 units / 500 mcg) and inject it into the tummy under the skin into the fatty skin layer, 3 times each day at equally spaced intervals.

How long will a vial last ?
A vial should last 33 days.